Product Program year 2025 Source: CMS Open Payments

Abilify Maintena

Drug Psychiatry

NDC 59148-018-71

Open in the dashboard

General payments

$19,963,787

229,986 payments

Research payments

$3,742,873

11 payments

Through program year 2025, $19,963,787 in general payments and $3,742,873 in research payments were reported against Abilify Maintena (Psychiatry).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $3,015,395 30,983
2024 General $3,545,763 34,303
2023 General $3,409,421 47,915
2022 General $2,970,995 46,217
2021 General $2,153,277 30,901
2021 Research $1,265,623 3
2020 General $1,408,811 11,340
2020 Research $232,915 3
2019 General $3,460,125 28,327
2019 Research $2,244,335 5

Breakdown

Who paid General payments · program years 2019–2025
  1. Otsuka America Pharmaceutical, Inc. $18,176,159 201,084 payments
  2. H. Lundbeck A S $969,709 410 payments
  3. Lundbeck LLC $518,692 27,540 payments
  4. Otsuka Pharmaceutical Development & Commercialization, Inc. $203,618 905 payments
  5. Otsuka Pharmaceutical Co., Ltd. $95,608 47 payments
Top recipients General payments · program year 2025
  1. Rifaat El-Mallakh Psychiatry · Louisville, KY $104,026 3% · 114 payments
  2. Henry Nasrallah Psychiatry · Cincinnati, OH $81,591 3% · 94 payments
  3. Ilan Melnick Psychiatry · Coral Gables, FL $80,682 3% · 74 payments
  4. Kent McDaniel Psychiatry · Glen Allen, VA $79,199 3% · 72 payments
  5. Tracey Skale Psychiatry · Cincinnati, OH $76,799 3% · 97 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Psychiatry Psychiatry & Neurology $2,140,883 71% · 2,298 practitioners
  2. Nurse Practitioner, Psychiatric/Mental Health Nurse Practitioner $539,400 18% · 5,038 practitioners
  3. Physician Assistant $83,982 3% · 631 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $63,167 2% · 1,023 practitioners
  5. Child & Adolescent Psychiatry Psychiatry & Neurology $59,520 2% · 187 practitioners

The top 5 of 104 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $317,320 11% · 750 recipients
  2. Ohio $308,565 10% · 713 recipients
  3. Texas $236,359 8% · 739 recipients
  4. California $234,401 8% · 711 recipients
  5. Florida $214,487 7% · 747 recipients

The top 5 of 54 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

189,533

Prescriptions dispensed, refills included

Drug cost

$514,648,932

Paid at the pharmacy, in all

Medicare Part D drugs matched to ABILIFY MAINTENA, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Abilify Maintena Aripiprazole Same name 7,323 187,418 $512,868,771
Abilify Aripiprazole Similar name 145 2,115 $1,780,161

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 199 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Ileana Berman Psychiatry MA 386 $1,027,377 None on record
Kendrick James Nurse Practitioner SC 237 $676,474 $24
Mohammed Bari Psychiatry CA 204 $571,212 $154
Anissa Thomas Nurse Practitioner AL 202 $573,009 $232
Jillian O'Grady Nurse Practitioner WI 197 $572,215 $40

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 199 with Patron

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to ABILIFY MAINTENA
Billing code Providers Services Paid by Medicare
Injection, aripiprazole, extended release, 1 mg J0401 2 96 $437

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

229,986 general · 11 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record